Abstract 3386
Background
The important issue of psychophysiological adaptation to malignant process is poorly studied. The aim of the research was to elucidate characteristics of the psychic, adaptive and hormonal status of patients with lung cancer (LC).
Methods
Studies were performed in 28 LC patients with receiving surgery and chemoradiotherapy. The patients were divided into 3 groups: 1 - unresectable tumors, 2 - resectable tumors with metastases, 3 - resectable tumors without detected metastases. Personal (PA) and situational anxiety (SA) (Spielberger-Khanin test), depression (Zung test), the types of the mental response to disease (LOBI, Bechterew Institute Personality Inventory) were evaluated. With the help of blood count and the original computer program "Antistress", we calculated the quantitative indicator (QI) of the general nonspecific adaptation reactions of the body (AR) (Garkavi L. H. et al., 1975). Hormone levels of thyroid and pituitary-adrenal (PAS) systems in the blood were determined by electrochemiluminescent method (Cobase 411E).
Results
The studied groups did not differ in PA and SA. The signs of tension of the PAS, elevated thyroxine level and decline in the adaptive status were noted. At the same time, QI of AR in patients of the group 3 was 1.8-2.7 times higher than in patients of other groups (p < 0.05). Depression was observed in only one patient. The euphoric type of response to the disease dominated in the groups (39% of cases), the harmonic type was the second most frequent (18% of cases). The patients of group 3 with euphoric reaction (referred to non-rational types of response) were characterized by an uncomplicated postoperative period and the maximal QI of AR in the studied groups, which exceeded by 2 times the indices in the patients of group 3 with harmonic and other reactions (p < 0.01).
Conclusions
QI of AR of patients with LC reflected the prevalence of the malignant process. In these patients depression was not expressed, and the euphoric reaction dominated. That could be due to central effects of thyroxin. We assumed that the euphoric reaction in the patients with resectable LC without detected metastases was a favorable diagnostic characteristic. So the questions arise about the clarification of the concept of the euphoric reaction and the ways of its identification.
Clinical trial identification
Legal entity responsible for the study
Ministry of Health of the Russian Federation.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2595 - Real-Life Utilization of Genomic testing for invasive Breast Cancer patients in Italy and France reduces Chemotherapy Recommendations
Presenter: Sandro Barni
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2343 - Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
Presenter: Alexandre De Nonneville
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2990 - Baseline lymphocyte counts predict distant recurrence in early breast cancer
Presenter: Gun Min Kim
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4532 - A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure Invasive Lobular Breast Carcinoma (ILC).
Presenter: Luisa Carbognin
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2344 - Benefit of Adjuvant Systemic Therapies in HR+ HER2- pT1ab Node-Negative Breast Carcinomas
Presenter: Alexandre De Nonneville
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3525 - Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): an open-label, randomized, three-arm, multicenter, window-of-opportunity study
Presenter: Aleix Prat
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3908 - Clinicopathologic significance of androgen receptor expression and discordant receptor status during progression in breast cancer
Presenter: Chan Heun Park
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4075 - The outcomes of early breast cancers utilizing the Oncotype Dx Recurrence score (RS) instead of Clinico-pathological (CP) factors for prognostic risk assessment: A Single Institution Experience
Presenter: Adhar Alsayed
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
738 - Circulating tumor cells as a prognostic marker in non metastatic breast cancer patients.
Presenter: Summar Elmorshidy
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3151 - Molecular subtyping of breast cancer by dedicated breast PET
Presenter: Satoshi Sueoka
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract